1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Perspective (2017-2028)
2.2 Amyotrophic Lateral Sclerosis Therapeutics Growth Trends by Region
2.2.1 Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Amyotrophic Lateral Sclerosis Therapeutics Market Dynamics
2.3.1 Amyotrophic Lateral Sclerosis Therapeutics Industry Trends
2.3.2 Amyotrophic Lateral Sclerosis Therapeutics Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis Therapeutics Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Therapeutics Revenue
3.4 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2021
3.5 Amyotrophic Lateral Sclerosis Therapeutics Key Players Head office and Area Served
3.6 Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
3.7 Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2023-2028)
5 Amyotrophic Lateral Sclerosis Therapeutics Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2017-2028)
6.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
6.2.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2017-2028)
6.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
6.3.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2017-2028)
6.4 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
6.4.1 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size (2017-2028)
7.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
7.2.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2017-2028)
7.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
7.3.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2017-2028)
7.4 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
7.4.1 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size (2017-2028)
9.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
9.2.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
9.3.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
9.4.1 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Details
11.1.2 Mitsubishi Tanabe Pharma Business Overview
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.1.5 Mitsubishi Tanabe Pharma Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.2.5 Sanofi Recent Developments
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Details
11.3.2 Mylan Pharma Business Overview
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.3.5 Mylan Pharma Recent Developments
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.4.5 Apotex Recent Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Company Details
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.5.5 Glemark Generics Recent Developments
11.6 Covis Pharma
11.6.1 Covis Pharma Company Details
11.6.2 Covis Pharma Business Overview
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.6.5 Covis Pharma Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.7.5 Sun Pharma Recent Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Details
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
11.8.5 Lunan Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone (Radicava)
Table 4. Key Players of Other
Table 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2017-2022)
Table 9. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region (2023-2028)
Table 11. Amyotrophic Lateral Sclerosis Therapeutics Market Trends
Table 12. Amyotrophic Lateral Sclerosis Therapeutics Market Drivers
Table 13. Amyotrophic Lateral Sclerosis Therapeutics Market Challenges
Table 14. Amyotrophic Lateral Sclerosis Therapeutics Market Restraints
Table 15. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Players (2017-2022)
Table 17. Global Top Amyotrophic Lateral Sclerosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2021)
Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis Therapeutics Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Amyotrophic Lateral Sclerosis Therapeutics Product Solution and Service
Table 22. Date of Enter into Amyotrophic Lateral Sclerosis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2017-2022)
Table 26. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Market Share by Type (2023-2028)
Table 28. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Application (2017-2022)
Table 30. Global Amyotrophic Lateral Sclerosis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis Therapeutics Revenue Share by Application (2023-2028)
Table 32. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 62. Mitsubishi Tanabe Pharma Company Details
Table 63. Mitsubishi Tanabe Pharma Business Overview
Table 64. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 65. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Mitsubishi Tanabe Pharma Recent Developments
Table 67. Sanofi Company Details
Table 68. Sanofi Business Overview
Table 69. Sanofi Amyotrophic Lateral Sclerosis Therapeutics Product
Table 70. Sanofi Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 71. Sanofi Recent Developments
Table 72. Mylan Pharma Company Details
Table 73. Mylan Pharma Business Overview
Table 74. Mylan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 75. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 76. Mylan Pharma Recent Developments
Table 77. Apotex Company Details
Table 78. Apotex Business Overview
Table 79. Apotex Amyotrophic Lateral Sclerosis Therapeutics Product
Table 80. Apotex Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 81. Apotex Recent Developments
Table 82. Glemark Generics Company Details
Table 83. Glemark Generics Business Overview
Table 84. Glemark Generics Amyotrophic Lateral Sclerosis Therapeutics Product
Table 85. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 86. Glemark Generics Recent Developments
Table 87. Covis Pharma Company Details
Table 88. Covis Pharma Business Overview
Table 89. Covis Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 90. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 91. Covis Pharma Recent Developments
Table 92. Sun Pharma Company Details
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 95. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Sun Pharma Recent Developments
Table 97. Lunan Pharma Company Details
Table 98. Lunan Pharma Business Overview
Table 99. Lunan Pharma Amyotrophic Lateral Sclerosis Therapeutics Product
Table 100. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022) & (US$ Million)
Table 101. Lunan Pharma Recent Developments
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Riluzole Features
Figure 3. Edaravone (Radicava) Features
Figure 4. Other Features
Figure 5. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Drugs Store Case Studies
Figure 8. Other Case Studies
Figure 9. Amyotrophic Lateral Sclerosis Therapeutics Report Years Considered
Figure 10. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Amyotrophic Lateral Sclerosis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Region: 2021 VS 2028
Figure 13. Global Amyotrophic Lateral Sclerosis Therapeutics Market Share by Players in 2021
Figure 14. Global Top Amyotrophic Lateral Sclerosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Therapeutics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Therapeutics Revenue in 2021
Figure 16. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 18. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 19. North America Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Country (2017-2028)
Figure 20. United States Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 24. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 25. Europe Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Country (2017-2028)
Figure 26. Germany Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Region (2017-2028)
Figure 36. China Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Country (2017-2028)
Figure 46. Mexico Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Amyotrophic Lateral Sclerosis Therapeutics Market Size Share by Country (2017-2028)
Figure 52. Turkey Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Amyotrophic Lateral Sclerosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 56. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 57. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 58. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 59. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 60. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 61. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 62. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Therapeutics Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
